• 18543 Citations
  • 70 Scopus h-Index
1976 …2019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Alex Adjei is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 24 Similar Profiles
Non-Small Cell Lung Carcinoma Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Pemetrexed Medicine & Life Sciences
gemcitabine Medicine & Life Sciences
Lung Neoplasms Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Farnesyltranstransferase Medicine & Life Sciences
irinotecan Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 1976 2019

RPMI CORE CENTER GRANT

Adjei, A.

Project: Research project

PHASE I CLINICAL TRIALS OF ANTICANCER AGENTS

Erlichman, C., Adjei, A. & Adjei, A.

National Institutes of Health

6/1/952/28/14

Project: Research project

Clinical Trials, Phase I
Antineoplastic Agents
Pharmacokinetics
Pharmaceutical Preparations
Maximum Tolerated Dose

Research Output 1985 2019

1 Citation (Scopus)

5-year overall survival in patients with lung cancer eligible or ineligible for screening according to US Preventive Services Task Force criteria: a prospective, observational cohort study

Luo, Y. H., Luo, L., Wampfler, J. A., Wang, Y., Liu, D., Chen, Y. M., Adjei, A., Midthun, D. E. & Yang, P., Aug 1 2019, In : The Lancet Oncology. 20, 8, p. 1098-1108 11 p.

Research output: Contribution to journalArticle

Open Access
Advisory Committees
Observational Studies
Lung Neoplasms
Cohort Studies
Survival
1 Citation (Scopus)

Antibody-Drug Conjugates for the Therapy of Thoracic Malignancies

Xie, H. & Adjei, A., Mar 1 2019, In : Journal of Thoracic Oncology. 14, 3, p. 358-376 19 p.

Research output: Contribution to journalReview article

Thorax
Drug Therapy
Antibodies
Neoplasms
Pharmaceutical Preparations

A phase II study of the orally administered negative enantiomer of gossypol (AT-101), a BH3 mimetic, in patients with advanced adrenal cortical carcinoma

Xie, H., Yin, J., Shah, M. H., Menefee, M. E., Bible, K. C., Reidy-Lagunes, D., Kane, M. A., Quinn, D. I., Gandara, D. R., Erlichman, C. & Adjei, A., Jan 1 2019, In : Investigational New Drugs.

Research output: Contribution to journalArticle

Gossypol
Adrenocortical Carcinoma
Troponin
Hypokalemia
B-Cell Lymphoma

A Proposed System Toward Standardizing Surgical-Based Treatments for Malignant Pleural Mesothelioma, From the Joint National Cancer Institute–International Association for the Study of Lung Cancer–Mesothelioma Applied Research Foundation Taskforce

Friedberg, J. S., Culligan, M. J., Tsao, A. S., Rusch, V., Sepesi, B., Pass, H. I., Bueno, R., Burt, B., Sugarbaker, D. J., de Perrot, M., Adjei, A., Adusumilli, P. S., Hirsch, F. R., Malik, S. M. & Harpole, D. J., Aug 1 2019, In : Journal of Thoracic Oncology. 14, 8, p. 1343-1353 11 p.

Research output: Contribution to journalReview article

Joints
Mesothelioma
Lung
Research
Neoplasms
37 Citations (Scopus)

Control of confounding and reporting of results in causal inference studies

Lederer, D. J., Bell, S. C., Branson, R. D., Chalmers, J. D., Marshall, R., Maslove, D. M., Ost, D. E., Punjabi, N. M., Schatz, M., Smyth, A. R., Stewart, P. W., Suissa, S., Adjei, A., Akdis, C. A., Azoulay, É., Bakker, J., Ballas, Z. K., Bardin, P. G., Barreiro, E., Bellomo, R. & 28 others, Bernstein, J. A., Brusasco, V., Buchman, T. G., Chokroverty, S., Collop, N. A., Crapo, J. D., Fitzgerald, D. A., Hale, L., Hart, N., Herth, F. J., Iwashyna, T. J., Jenkins, G., Kolb, M., Marks, G. B., Mazzone, P., Moorman, J. R., Murphy, T. M., Noah, T. L., Reynolds, P., Riemann, D., Russell, R. E., Sheikh, A., Sotgiu, G., Swenson, E. R., Szczesniak, R., Szymusiak, R., Teboul, J. L. & Vincent, J. L., Jan 1 2019, In : Annals of the American Thoracic Society. 16, 1, p. 22-28 7 p.

Research output: Contribution to journalReview article

Critical Care
Causality
Sleep
Epidemiology
Research Design